Meilstrup Eric J

CEO Meilstrup buys 500 LCNB shares at $17.42; post-trade holdings 46,205 shares (+1.1%)

Meilstrup Eric J, as CEO, purchased 500 shares at $17.42 on 2025-02-17, bringing his total holdings to 46,205 shares. The current price of $17.59 places the purchase only 1.5% below the 52-week high, and the stock has gained 5.4% over the past 30 days and 15.3% over 90 days. His prior buy on 2025-11-19 at LCNB followed with a 10.0% 30-day return, and 4 of 5 of his prior buys at this ticker achieved positive 90-day returns, demonstrating a pattern of well-timed purchases. The company trades at a P/E of 10.60 with $249.5M market cap and generated $6.9M in net income on $1.1M in latest quarterly revenue. This incremental accumulation by the CEO at a price near recent highs, combined with the historically well-timed buy pattern at this ticker, reflects ongoing conviction at current valuations.

CEO Meilstrup buys 500 LCNB shares at $15.32; prior trades show mixed signals with 60% 90-day win rate at this ticker.

CEO Eric J Meilstrup purchased 500 shares at $15.32 on 2025-11-19, a modest 1.1% increase to his 45.7K-share position. His prior trades at LCNB show a split record: 3 of 5 prior buys were well-timed at the 90-day mark (positive 90-day returns), while 2 resulted in losses (the 2025-02-17 and 2024-11-26 buys each showed -13.4% and -12.4% declines, respectively). The stock is currently down 13.2% from its 52-week high at $17.63 but has gained 4.0% over the past 30 days. The company trades at a P/E of 9.22 with $6.9M net income on $1.1M quarterly revenue. The transaction provides moderate directional data but lacks a decisive pattern: three successful prior buys do not overpower two significant losses in the same-ticker history.

CEO Meilstrup buys 200 shares of LCNB at $14.51; stock down 18.9% from 52-week high, mixed timing on prior buys.

Meilstrup Eric J, CEO & President, purchased 200 shares at $14.51 on 2025-05-28, increasing his holdings from 45,005 to 45,205 shares. The stock is currently trading at $14.30, down 18.9% from its 52-week high of $17.63, and has declined 2.7% over the past 30 days. Examining his prior trade timing at LCNB specifically: he achieved positive 90-day returns on 3 of 5 prior buys, with notably strong +13.0% at 90 days on his 2024-08-29 purchase and +6.8% on his 2024-02-07 purchase; however, his two most recent LCNB buys (2024-11-26 and 2025-02-17) each showed negative 90-day returns of -18.4% and -11.0% respectively, indicating deteriorating timing precision at this ticker in recent months. The company's fundamentals show a P/E of 12.54 with net income of $4,609,000.00 against revenue of $1,139,000.00, though the modest transaction size of $2,902.94 relative to his existing 45.2K share position suggests routine portfolio activity rather than a material shift in conviction.

CEO Eric J Meilstrup buys 250 LCNB shares at $17.54; stock up 15.8% in 30 days, 11.7% in 90 days.

CEO Eric J Meilstrup purchased 250 shares at $17.54 on 2024-11-26, increasing his holdings to 39,210 shares. This open-market buy occurs amid strong recent price momentum: the stock has rallied 15.8% over 30 days and 11.7% over 90 days, currently trading at $17.27 (within 2.0% of its 52-week high of $17.63). His prior two completed trades at LCNB (February 2024 and May 2023) both showed positive 90-day returns of 6.8% and 9.0% respectively, suggesting consistent well-timed entries. However, the current transaction represents a small position increase (+0.6% of pre-transaction holdings valued at $4.4K), and occurs at a price near the stock's recent highs, which differs from the pattern of his prior buys executed at lower relative valuations.

CEO Eric J Meilstrup buys 350 shares of LCNB at $15.39; prior 2 same-ticker buys both posted 90d gains.

CEO Meilstrup purchased 350 shares at $15.39, increasing his holdings to 38,960 shares. His prior 2 same-ticker buys (2024-02-07 and 2023-05-25) both generated positive 90-day returns of +6.8% and +9.0% respectively, establishing a pattern of well-timed purchases at LCNB. The stock currently trades at $15.69, +3.5% over 30 days and +11.3% over 90 days, consistent with the upward trajectory observed after his prior transactions. With P/E of 33.38 and quarterly net income of $925,000.00, the company shows operational profitability, though valuation is elevated relative to historical baseline.